Abstract:Aptamers that bind to neurotoxins are encapsulated into metal–organic framework cores and then coated with neuronal cell membrane. The resulting aptamer‐loaded cellular nanoparticles combine membrane‐enabled broad‐spectrum neutralization with aptamer‐based specific toxin binding, offering dual‐modal neutralization mechanisms for efficient neurotoxin neutralization. Such neutralization capability is validated in vivo using mouse models of neurotoxin intoxication. Aptamers are single‐stranded oligonucleotides that fold into defined architectures for specific target binding. In this study, aptamers are selected that specifically bind to small‐molecule neurotoxins and encapsulate them into cell membrane‐coated nanoparticles (referred to as 'cellular nanoparticles' or 'CNPs') for effective neutralization of neurotoxins. Specifically, six different aptamers are selected that bind to saxitoxin (STX) or tetrodotoxin (TTX) and encapsulate them into metal–organic framework cores, which are then coated with neuronal cell membrane. The resulting CNPs exhibit high colloidal stability, minimal aptamer leakage, and effective protection of aptamer payloads against enzyme degradation. This detoxification platform combines membrane‐enabled broad‐spectrum neutralization with aptamer‐based specific toxin binding, offering dual‐modal neutralization mechanisms for efficient neurotoxin neutralization. The in vitro neutralization efficacy is demonstrated using a neuron osmotic swelling assay, a Na+ flux fluorescence assay, and a cytotoxicity assay. The in vivo neutralization efficacy is further validated using mouse models of STX and TTX intoxication in both therapeutic and preventative regimens. Overall, integrating aptamers with CNPs combines the strengths of both technologies, resulting in a robust solution for broad‐spectrum toxin‐neutralization applications.

Neuronal Membrane-Derived Nanodiscs for Broad-Spectrum Neurotoxin Detoxification

Dual-Modal Cellular Nanoparticles for Continuous Neurotoxin Detoxification

Protein‐Loaded Cellular Nanosponges for Dual‐Biomimicry Neurotoxin Countermeasure

A Genetically Engineered Neuronal Membrane-Based Nanotoxoid Elicits Protective Immunity Against Neurotoxins

Detoxification Using Nanoparticles

Aptamer‐Encapsulated Cellular Nanoparticles for Neurotoxin Neutralization

Designing Nanodiscs as Versatile Platforms for On-Demand Therapy

Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures

Nanodiscs: A toolkit for membrane protein science

Hydrogel Retaining Toxin‐Absorbing Nanosponges for Local Treatment of Methicillin‐Resistant Staphylococcus Aureus Infection

Neutrophil Decoys with Anti‐Inflammatory and Anti‐Oxidative Properties Reduce Secondary Spinal Cord Injury and Improve Neurological Functional Recovery

A Facile Approach to Functionalizing Cell Membrane-Coated Nanoparticles with Neurotoxin-Derived Peptide for Brain-Targeted Drug Delivery.

DeFrND: detergent-free reconstitution into native nanodiscs with designer membrane scaffold peptides

The application of nanodiscs in membrane protein drug discovery & development and drug delivery

An in vitro nerve agent brain poisoning transwell model for convenient and accurate antidote evaluation

Nano-Neurotheranostics: Impact of Nanoparticles on Neural Dysfunctions and Strategies to Reduce Toxicity for Improved Efficacy

Designed Nanodrugs for Ultrasonic Removal of Toxic Polyglutamine Aggregates from Neuron Cells

Potential application of aptamers combined with DNA nanoflowers in neurodegenerative diseases

A biomimic anti-neuroinflammatory nanoplatform for active neutrophil extracellular traps targeting and spinal cord injury therapy

Cell-Membrane-Coated Nanoparticles for Targeted Drug Delivery to the Brain for the Treatment of Neurological Diseases

Platelet Membrane‐Derived Nanodiscs for Neutralization of Endogenous Autoantibodies and Exogenous Virulence Factors